CPNP common mistakes are rarely dramatic. Almost nobody gets caught out by an exotic regulatory technicality — they get caught out by a mismatch between the INCI list on the carton and the formula in the notification, by picking the wrong frame formulation, or by launching a reformulated product and never going back to update the record.
The Cosmetic Products Notification Portal has no approval step, which is exactly what makes it dangerous. You submit, you get a reference number, and nothing tells you that you got it wrong. The error surfaces months later during a market surveillance inspection, in a customs hold, in a retailer audit, or — worst case — when a poison centre pulls up your product for a clinician and the data does not match what is in the bottle. This guide covers the mistakes we see most often and how to avoid each one.
Key takeaways
- CPNP is a notification, not an approval — there is no validation step, so errors sit undetected until an inspection.
- The most common rejection trigger is an INCI list on the label that does not match the notified formula.
- Incomplete formulas — omitting water, preservatives, fragrance components or colorants — are the second most frequent error.
- Choosing the wrong frame formulation or the wrong product category leads directly to authority enquiries.
- Reformulating without updating the notification breaches Article 13(4); the duty to keep it current is continuous.
- Only the Responsible Person can notify — a non-EU brand cannot notify in its own name.
- Nano materials, CMR substances and products for under-3s all trigger additional obligations that are routinely missed.
Mistake 1: The label and the notification disagree
This is the number one reason notifications are queried, and it is almost always a version control problem rather than a knowledge problem.
Article 13 requires the notification to include the presence of substances of concern, the frame formulation, and — critically — an electronic copy of the original labelling and a photograph of the corresponding packaging where reasonably legible. An inspector comparing your uploaded artwork against your notified composition should see the same product. Frequently they do not, because:
- The formula was tweaked after artwork was signed off, and only one of them was updated.
- A fragrance was changed for a variant and the ingredient list was rolled forward from the previous SKU.
- The uploaded artwork is an older revision that happened to be the file on someone’s desktop.
- The ingredient list order does not follow descending weight, so the two documents describe different-looking products even though the composition matches.
The fix: treat the label and the notification as a single deliverable that must be signed off together. Before you notify, put the INCI list from the artwork side by side with the formula in the notification and check them line by line, in order. Our INCI list preparation guide covers the declaration rules that make the two match in the first place.
This is not a paperwork nicety. The notified composition is what a poison centre gives to a clinician treating an exposure. A mismatch between the notification and the actual product is a patient safety issue, and authorities treat it accordingly.
Mistake 2: An incomplete formula
The formulation entered into CPNP must be complete. Every ingredient, at its actual concentration — including the ones people forget because they feel like they do not count:
- Water. Usually the largest component and routinely omitted because it feels like a base rather than an ingredient.
- Preservatives supplied as part of a blend, where only the trade name is recorded.
- Fragrance components — the parfum is a mixture and its declarable components need to be reflected.
- Colorants, especially across a shade range where a “may contain” list was used on the label.
- Carriers and solvents that arrive inside a raw material rather than being weighed in separately.
The fix: build the notification from the manufacturing formula and the raw material specifications, not from the label. A raw material that is “Preservative Blend X” on your bill of materials is three or four INCI entries in the notification. Ask suppliers for the full quantitative composition of every compound raw material — you need it for the CPSR anyway. See the documents needed to order a CPSR.
Mistake 3: The wrong frame formulation
Frame formulations are standardised composition templates with concentration ranges, designed so that poison centres get usable data without every brand disclosing exact percentages. Choosing the closest-looking one is not good enough.
Two failure modes dominate. The first is picking a frame that does not actually cover your product type — filing a lip balm under a generic skin care frame, for example. The second is missing the triggered questions: many frames ask supplementary questions about specific components, and answering them carelessly (or skipping them where the portal allows) produces a notification that does not reflect the product.
The fix: read the frame formulation text in full before selecting, confirm your product falls within every stated concentration range, and answer triggered questions from the actual formula. Where no frame fits — which happens with unusual formats and borderline products — the correct answer is to submit the exact quantitative formulation rather than force a bad fit.
If any ingredient in your formula falls outside the concentration range of the frame you have chosen, that frame is not valid for your product. This is the single most common technical error in frame selection, and it is entirely avoidable by checking ranges rather than category names.
Mistake 4: The wrong product category
CPNP uses a hierarchical product category tree, and your selection drives how authorities and poison centres interpret the submission. Miscategorisation is common with multifunctional and hybrid products — is a tinted SPF moisturiser a sun product, a make-up product or a skin care product? Is a cleansing balm a cleanser or a make-up remover?
The fix: categorise by the product’s primary function as presented to the consumer, and be consistent across your portfolio. Where a product genuinely straddles categories, choose the one carrying the more stringent expectations — a tinted SPF product notified as sun care is safer than the reverse, because sun products attract specific requirements around SPF and UVA that a skin care categorisation would obscure.
Mistake 5: Notifying under the wrong entity
Only the Responsible Person can submit a notification under Article 13(1). A brand based outside the EU cannot notify in its own name, and a distributor notifying “on behalf of” a brand without being properly appointed does not fix it.
This causes real commercial damage when the relationship ends. If a distributor notified your products under their own RP role, they control those CPNP records — and moving markets or changing partners means renotifying everything. We see this most often with brands that appointed a market-entry distributor as RP for convenience and later wanted independence.
The fix: establish who your RP is before notifying, put the appointment in writing with a mandate that survives commercial changes, and make sure the RP name and address on the pack matches the notifying entity. Our guides on what an EU Responsible Person is and how to find one cover the appointment.
Mistake 6: Treating notification as a one-off
Article 13(4) requires the Responsible Person to update the notification when any of the notified information changes. The duty is continuous, and it is the most widely ignored obligation in the whole framework.
Changes that require an update include:
| Change | Update required? |
|---|---|
| Reformulation, even minor | Yes — if it affects the frame formulation or substances of concern |
| New fragrance in an existing base | Yes |
| Preservative system change | Yes |
| New shade added to a range | Yes — as a new product or an update, depending on structure |
| Artwork revision affecting mandatory information | Yes |
| Change of Responsible Person | Yes |
| New country of placing on the market | Yes |
| Product permanently withdrawn | Update the record accordingly |
| Marketing copy change with no label impact | No |
The fix: tie the CPNP record to your change control process. Any formula or artwork change order should carry a mandatory field asking whether CPNP needs updating, answered by someone who knows the answer.
Adding a new country of sale is an update too. Brands that notified for one market and later expanded across the EU frequently never went back to add the additional countries — which means the poison centres in those countries hold no data for a product being sold there.
Mistake 7: Missing the special-case obligations
Three situations carry obligations beyond the standard notification, and all three are regularly missed.
Nanomaterials
Products containing nanomaterials require notification six months before placing on the market under Article 16, separately from and in addition to the Article 13 notification. The nanomaterial must also be identified in the ingredient list with “[nano]” after the name. Nano titanium dioxide and zinc oxide in sun care are the usual triggers.
CMR substances
Where a product contains a substance classified as carcinogenic, mutagenic or toxic for reproduction in category 1A or 1B and permitted by way of derogation under Article 15, the notification must reflect it and the derogation conditions must be met.
Products for children under three
Article 13 requires notification of the presence of substances of concern and specifically flags products intended for children under three. This drives poison centre risk assessment, and getting it wrong on a baby product is a serious finding. Our guide to CPSR requirements for baby cosmetics covers the wider obligations.
Mistake 8: Confusing CPNP with PCN
These are different systems under different regulations, and brands with hybrid portfolios file the wrong one or assume one covers the other.
CPNP sits under the Cosmetic Products Regulation and covers cosmetics. PCN sits under Annex VIII of CLP and covers hazardous mixtures, requiring a UFI on the label. Most finished cosmetics are outside PCN, but cosmetic-adjacent products — a nail product classified as a hazardous mixture, a room fragrance, a professional salon chemical — can need PCN, and some products need both. Our comparison of PCN vs CPNP sets out which applies when.
A pre-submission checklist
Run this before you hit submit:
- Formula in CPNP is the current manufacturing formula, complete, including water and all compound raw material components.
- Label INCI list matches that formula, in descending weight order, and the uploaded artwork is the current revision.
- Frame formulation selected covers the product type and every ingredient falls within its ranges; triggered questions answered from the formula.
- Product category reflects primary function, consistently with the rest of your range.
- Notifying entity is the RP named on the pack, with a written mandate in place.
- Every country where the product will be sold is listed.
- Nano, CMR and under-3s flags checked and handled.
- Substances of concern and, where relevant, pH declared.
- CPSR is signed and the PIF is complete — the notification should be the last step, not the first.
- The CPNP reference number is recorded against the product in your own records.
Notify after your safety assessment is signed, not before. Assessors frequently require formulation changes — a preservative at a different level, a fragrance allergen adjustment — and a notification filed in advance of the CPSR is very likely to need immediate correction.
Bringing it all together
The CPNP is deceptively easy. There is no gatekeeper, no approval letter and no error message, so a notification with the wrong frame formulation, an incomplete formula and outdated artwork looks exactly like a perfect one from the outside. The consequences appear later, and by then the product is in the channel across multiple markets.
Nearly every mistake on this list comes from the same root cause: the notification is treated as an administrative task done once, by whoever is free, from whatever documents are to hand. Treated properly — as the final step of a controlled process that starts with the formula and ends with signed-off artwork, and that gets revisited every time either changes — CPNP becomes routine.
Lexora files CPNP notifications as part of a complete compliance file, so the formula, the label and the notification are checked against each other before anything is submitted. Explore our CPNP notification service, or take safety assessment, labelling and notification together with the Full Compliance Pack.
Frequently asked questions
Can a CPNP notification be rejected?
The portal itself does not approve or reject notifications — it accepts a submission and issues a reference. What happens instead is that errors surface later as enquiries from national competent authorities, findings during market surveillance inspections, customs holds, or retailer audit failures. The absence of a rejection is not confirmation that the notification is correct.
What is the most common CPNP error?
A mismatch between the INCI list on the label and the composition in the notification. It usually comes from a formula change that reached only one of the two documents, or from uploading an outdated artwork file. Checking the two side by side before submitting eliminates most of it.
Do I have to update the notification if I change my formula?
Yes. Article 13(4) requires the Responsible Person to update the notification whenever notified information changes, and that includes reformulations affecting the frame formulation or substances of concern, preservative or fragrance changes, new shades, artwork revisions affecting mandatory information, a change of RP and adding a new country of sale.
Can my non-EU company notify its own products?
No. Only the Responsible Person, who must be established in the EU, can submit the notification under Article 13(1). A brand outside the Union must appoint an EU-based RP, and that entity notifies. Make sure the appointment is in writing and that the RP named on the pack is the notifying entity.
When should I notify — before or after the CPSR?
After. Safety assessors frequently require formulation changes, so notifying before the CPSR is signed usually means correcting the notification straight away. The right order is: finalise the formula, complete testing, get the CPSR signed, finalise artwork, then notify — and notification must be complete before the product is placed on the market.
Do I need a separate notification for each EU country?
No. One CPNP notification covers the whole EU, but you must list every country where the product is placed on the market so that the relevant national poison centres receive the frame formulation. Expanding into new markets means updating the existing notification, not creating a new one.
What is the difference between CPNP and PCN?
CPNP is cosmetic notification under Regulation (EC) No 1223/2009. PCN is poison centre notification under Annex VIII of CLP for hazardous mixtures, and requires a UFI code on the label. Most finished cosmetics need only CPNP, but cosmetic-adjacent products classified as hazardous mixtures can need PCN as well. See our guide to PCN vs CPNP.
